Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed)
This grant supports projects using genome or epigenome editing to study genes or genetic variants related to substance use disorders. Results should be shared widely to help researchers understand the brain mechanisms involved, aiding future prevention, diagnosis, and treatment strategies.
Source
Award
Dates
Program & Phase
Keywords
Supporting Links
Documents
Similar Opportunities
-
NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed)
National Institutes of Health
-
GREGoRi Innovation Projects (U01 Clinical Trial Optional)
National Institutes of Health
-
Enabling Discovery through GEnomics
National Science Foundation
-
Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)
National Institutes of Health
-
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)
National Institutes of Health
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers